These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 354202)

  • 21. [Recurrence and survival rate of advanced gastric cancer after preoperative intraarterial EAP I injection therapy].
    Takeuchi K; Taniguchi H; Miyata K; Koyama H; Tanaka H; Ueshima Y; Okano S; Oguro A; Itoh A; Sawai K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1654-6. PubMed ID: 8373240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A randomized controlled trial with methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) vs 5-FU alone in advanced or recurrent gastric carcinoma. Tokai Hokuriku THP Study Group].
    Yamamura Y; Miyazaki I; Ogawa M; Yonemura Y; Tanemura H; Kito T; Hamajima N; Saji S; Kosaka T
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1543-8. PubMed ID: 9725047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combination immunochemotherapy of 5-fluorouracil, cisplatin, leucovorin, and OK-432 for advanced and recurrent gastric carcinoma.
    Yoshikawa T; Tsuburaya A; Kobayashi O; Sairenji M; Motohashi H; Noguchi Y
    Hepatogastroenterology; 2003; 50(54):2259-63. PubMed ID: 14696512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does body mass index (BMI) influence morbidity and long-term survival in gastric cancer patients after gastrectomy?
    Moriwaki Y; Kunisaki C; Kobayashi S; Harada H; Imai S; Kasaoka C
    Hepatogastroenterology; 2003; 50(49):284-8. PubMed ID: 12630042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Patient survival rate in inoperable stomach cancer].
    Korman DB; Isaev NM; Kurguzov OP; Shkrob OS
    Vopr Onkol; 1980; 26(2):22-5. PubMed ID: 7361490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the effectiveness of radical surgical treatment in stomach cancer].
    Kustov VI
    Vopr Onkol; 1981; 27(4):90-4. PubMed ID: 7233882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 5-fluorouracil, methyl-CCNU, adriamycin, and mitomycin C in the treatment of advanced gastric cancer.
    Bunn PA; Nugent JL; Ihde DC; Cohen MH; Eddy JL; Minna JD
    Cancer Treat Rep; 1978 Sep; 62(9):1287-93. PubMed ID: 356983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].
    Yamaguchi K; Nakagawa S; Yabusaki H; Nashimoto A
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2241-4. PubMed ID: 18079622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of gastric cancer patients after successful gastrectomy: influence of the type of recurrence and histology on survival.
    Rohatgi PR; Yao JC; Hess K; Schnirer I; Rashid A; Mansfield PF; Pisters PW; Ajani JA
    Cancer; 2006 Dec; 107(11):2576-80. PubMed ID: 17075877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence-dependence of cisplatin and 5-fluorouracil in advanced and recurrent gastric cancer.
    Koizumi W; Kurihara M; Hasegawa K; Chonan A; Kubo Y; Maekawa R; Iwasaki R; Sasai T; Fukuyama Y; Ishikawa K; Miyoshi K; Yasutake K; Hayakawa M
    Oncol Rep; 2004 Sep; 12(3):557-61. PubMed ID: 15289837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [FLEP therapy for advanced and recurrent gastric cancer].
    Mochizuki F; Fujii M; Kasakura Y; Kochi M; Wakabayashi K; Eguchi T; Tsuneda Y; Kanamori N; Kaiga T; Kobayashi M
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1542-5. PubMed ID: 11707975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
    Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
    Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Etoposide, doxorubicin, cisplatin and 5-FU (EAP-F) therapy of advanced gastric cancer--its antitumor effect and evaluation of quality of life].
    Suda K; Kano Y; Inada T; Ogata Y
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1791-5. PubMed ID: 8379671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postoperative chemotherapy in elderly patients with advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Igarashi J; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T; Amano J
    Hepatogastroenterology; 2000; 47(36):1761-4. PubMed ID: 11149051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Locoregional recurrence of breast cancer: a retrospective comparison of treatment methods.
    Skowronek J; Piotrowski T
    Neoplasma; 2002; 49(6):426-31. PubMed ID: 12584593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
    Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of immunochemotherapy on the cases of advanced gastric cancer stage III].
    Miwa H; Ono F; Kobayashi T; Orita K
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1735-41. PubMed ID: 6820882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.